Orchard Therapeutics plc
ORTX · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$35,319 | -$12,307 | -$17,412 | -$7,883 |
| Dep. & Amort. | $652 | $655 | $643 | $721 |
| Deferred Tax | $677 | $206 | $242 | -$5,601 |
| Stock-Based Comp. | $2,468 | $2,578 | $3,512 | $3,926 |
| Change in WC | -$3,840 | -$6,290 | -$5,973 | $20,036 |
| Other Non-Cash | $11,470 | -$12,675 | -$10,520 | -$23,283 |
| Operating Cash Flow | -$23,892 | -$27,833 | -$29,508 | -$12,084 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$126 | $31 | -$514 | -$484 |
| Net Acquisitions | -$11,707 | $26,724 | $8,832 | $0 |
| Inv. Purchases | -$32,115 | -$75,724 | -$38,832 | -$41,075 |
| Inv. Sales/Matur. | $43,822 | $49,000 | $30,000 | $32,029 |
| Other Inv. Act. | $11,707 | -$26,724 | -$8,832 | $7,966 |
| Investing Cash Flow | $11,581 | -$26,693 | -$9,346 | -$1,564 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $34,000 | $34,000 | $0 |
| Stock Repurch. | -$13 | -$877 | -$12 | -$19 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,352 | $30,935 | $31,506 | -$811 |
| Financing Cash Flow | -$2,352 | $30,935 | $31,506 | -$811 |
| Forex Effect | -$141 | $377 | $411 | $2,081 |
| Net Chg. in Cash | -$14,804 | -$23,214 | -$6,937 | -$12,378 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $42,488 | $65,702 | $72,639 | $85,017 |
| End Cash | $27,684 | $42,488 | $65,702 | $72,639 |
| Free Cash Flow | -$24,018 | -$27,802 | -$30,022 | -$12,568 |